Suppr超能文献

通过应用于Cochrane系统评价评估临床试验可信度检查的可行性和影响:INSPECT-SR项目的第二阶段

Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project.

作者信息

Wilkinson Jack, Heal Calvin, Antoniou Georgios A, Flemyng Ella, Ahnström Love, Alteri Alessandra, Avenell Alison, Barker Timothy Hugh, Borg David N, Brown Nicholas J L, Buhmann Rob, Calvache Jose A, Carlsson Rickard, Carter Lesley-Anne, Cashin Aidan G, Cotterill Sarah, Färnqvist Kenneth, Ferraro Michael C, Grohmann Steph, Gurrin Lyle C, Hayden Jill A, Hunter Kylie E, Hyltse Natalie, Jung Lukas, Krishan Ashma, Laporte Silvy, Lasserson Toby J, Laursen David R T, Lensen Sarah, Li Wentao, Li Tianjing, Liu Jianping, Locher Clara, Lu Zewen, Lundh Andreas, Marsden Antonia, Meyerowitz-Katz Gideon, Mol Ben W, Munn Zachary, Naudet Florian, Nunan David, O'Connell Neil E, Olsson Natasha, Parker Lisa, Patetsini Eleftheria, Redman Barbara, Rhodes Sarah, Richardson Rachel, Ringsten Martin, Rogozińska Ewelina, Seidler Anna Lene, Sheldrick Kyle, Stocking Katie, Sydenham Emma, Thomas Hugh, Tsokani Sofia, Vinatier Constant, Vorland Colby J, Wang Rui, Al Wattar Bassel H, Weber Florencia, Weibel Stephanie, van Wely Madelon, Xu Chang, Bero Lisa, Kirkham Jamie J

机构信息

Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Centre for Biostatistics, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

出版信息

J Clin Epidemiol. 2025 May 9;184:111824. doi: 10.1016/j.jclinepi.2025.111824.

Abstract

BACKGROUND AND OBJECTIVES

The aim of the INveStigating ProblEmatic Clinical Trials in Systematic Reviews (INSPECT-SR) project is to develop a tool to identify problematic RCTs in systematic reviews. In stage 1 of the project, a list of potential trustworthiness checks was created. The checks on this list must be evaluated to determine which should be included in the INSPECT-SR tool.

METHODS

We attempted to apply 72 trustworthiness checks to randomized controlled trials (RCTs) in 50 Cochrane reviews. For each, we recorded whether the check was passed, failed, or possibly failed or whether it was not feasible to complete the check. Following application of the checks, we recorded whether we had concerns about the authenticity of each RCT. We repeated each meta-analysis after removing RCTs flagged by each check and again after removing RCTs where we had concerns about authenticity to estimate the impact of trustworthiness assessment. Trustworthiness assessments were compared to Risk of Bias and Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessments in the reviews.

RESULTS

Ninety-five RCTs were assessed. Following application of the checks, assessors had some or serious concerns about the authenticity of 25% and 6% of the RCTs, respectively. Removing RCTs with either some or serious concerns resulted in 22% of meta-analyses having no remaining RCTs. However, many checks proved difficult to understand or implement, which may have led to unwarranted skepticism in some instances. Furthermore, we restricted assessment to meta-analyses with no more than five RCTs (54% contained only 1 RCT), which will distort the impact on results. No relationship was identified between trustworthiness assessment and Risk of Bias or GRADE.

CONCLUSION

This study supports the case for routine trustworthiness assessment in systematic reviews, as problematic studies do not appear to be flagged by Risk of Bias assessment. The study produced evidence on the feasibility and impact of trustworthiness checks. These results will be used, in conjunction with those from a subsequent Delphi process, to determine which checks should be included in the INSPECT-SR tool.

PLAIN LANGUAGE SUMMARY

Systematic reviews collate evidence from randomized controlled trials (RCTs) to find out whether health interventions are safe and effective. However, it is now recognized that the findings of some RCTs are not genuine, and some of these studies appear to have been fabricated. Various checks for these "problematic" RCTs have been proposed, but it is necessary to evaluate these checks to find out which are useful and which are feasible. We applied a comprehensive list of "trustworthiness checks" to 95 RCTs in 50 systematic reviews to learn more about them and to see how often performing the checks would lead us to classify RCTs as being potentially inauthentic. We found that applying the checks led to concerns about the authenticity of around 1 in three RCTs. However, we found that many of the checks were difficult to perform and could have been misinterpreted. This might have led us to be overly skeptical in some cases. The findings from this study will be used, alongside other evidence, to decide which of these checks should be performed routinely to try to identify problematic RCTs, to stop them from being mistaken for genuine studies and potentially being used to inform health care decisions.

摘要

背景与目的

“系统评价中调查有问题的临床试验(INSPECT-SR)”项目的目的是开发一种工具,用于识别系统评价中有问题的随机对照试验(RCT)。在该项目的第一阶段,创建了一份潜在可信度检查清单。必须对清单上的检查进行评估,以确定哪些应纳入INSPECT-SR工具。

方法

我们尝试对50篇Cochrane系统评价中的随机对照试验应用72项可信度检查。对于每一项检查,我们记录其结果是通过、未通过、可能未通过,还是无法完成该检查。在应用这些检查后,我们记录是否对每项随机对照试验的真实性存在疑虑。在剔除每项检查标记的随机对照试验后,以及在剔除我们对其真实性存在疑虑的随机对照试验后,我们分别重复了每项荟萃分析,以评估可信度评估的影响。将可信度评估与系统评价中的偏倚风险和推荐分级评估、制定与评价(GRADE)评估进行比较。

结果

共评估了95项随机对照试验。应用这些检查后,评估者分别对25%和6%的随机对照试验的真实性存在一些或严重疑虑。剔除存在一些或严重疑虑的随机对照试验后,22%的荟萃分析中没有剩余的随机对照试验。然而,许多检查被证明难以理解或实施,这在某些情况下可能导致了无端的怀疑。此外,我们将评估限制在不超过5项随机对照试验的荟萃分析中(54%的荟萃分析仅包含1项随机对照试验),这会扭曲对结果的影响。未发现可信度评估与偏倚风险或GRADE之间存在关联。

结论

本研究支持在系统评价中进行常规可信度评估,因为有问题的研究似乎未被偏倚风险评估标记出来。该研究提供了关于可信度检查的可行性和影响的证据。这些结果将与后续德尔菲法的结果一起,用于确定哪些检查应纳入INSPECT-SR工具。

通俗易懂的总结

系统评价整理随机对照试验的证据,以确定健康干预措施是否安全有效。然而,现在人们认识到,一些随机对照试验结果并非真实,其中一些研究似乎是伪造的。针对这些“有问题”的随机对照试验提出了各种检查方法,但有必要对这些检查进行评估,以确定哪些有用、哪些可行。我们对50项系统评价中的95项随机对照试验应用了一份全面的“可信度检查”清单,以进一步了解这些检查,并了解进行这些检查会使我们将随机对照试验归类为可能不真实的频率。我们发现,应用这些检查会使约三分之一的随机对照试验的真实性受到质疑。然而,我们发现许多检查难以实施,可能会被误解。这可能导致我们在某些情况下过度怀疑。本研究的结果将与其他证据一起,用于决定应常规进行哪些检查,以试图识别有问题的随机对照试验,防止它们被误认为真实研究,并可能用于为医疗保健决策提供信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验